Article
Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus.
Pharmacogenetics - 1 Oct 1996
Agúndez J A, Menaya J G, Tejeda R, Lago F, Chávez M, Benítez J
Abstract excerpt
The arylamine N-acetyltransferase (NAT2) polymorphism has been related to the risk of developing non-insulin-dependent diabetes mellitus (NIDDM). Several studies suggested an excess of rapid acetylators among NIDDM patients. This may be explained by an increased risk to develop NIDDM among subjec...
Topics
- Acetylation
- Adult
- Aged
- Aged, 80 and over
- Arylamine N-Acetyltransferase
- Cytochrome P-450 CYP2D6
- Diabetes Mellitus, Type 2
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Phenotype
- Polymorphism, Genetic
- Risk Factors
- White People